Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R North

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of General Virology|February 1, 1983
Purification and properties of the gp340 component of Epstein-Barr virus membrane antigen in an immunogenic formA J Morgan, J R North, M A Epstein
Immunology|October 1, 1977
IgG anti-hapten antibody secretion in vitro commences after extensive precursor proliferationJ T Kemshead, J R North, B A Askonas
Immunology|September 1, 1977
Non-specific factor replaces T cells in an IgG response to soluble antigensJ R North, J T Kemshead, B A Askonas
Progress in Clinical and Biological Research|January 1, 1983
Vaccine control of malignancies induced by lymphotropic herpesvirusesM A Epstein, J R North, A J Morgan
Journal of Virological Methods|September 1, 1982
Quantification of an Epstein-Barr virus-associated membrane antigen componentJ R North, A J Morgan, J L Thompson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1982
Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomesJ R North, A J Morgan, J L Thompson, et al.
The Journal of General Virology|April 1, 1981
Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolatesS M Franklin, J R North, A J Morgan, et al.
Cancer Letters|April 27, 2001
Photodynamic therapy targeted to tumor-induced angiogenic vesselsK Kurohane, A Tominaga, K Sato, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of General Virology|February 1, 1983
Purification and properties of the gp340 component of Epstein-Barr virus membrane antigen in an immunogenic formA J Morgan, J R North, M A Epstein
Immunology|October 1, 1977
IgG anti-hapten antibody secretion in vitro commences after extensive precursor proliferationJ T Kemshead, J R North, B A Askonas
Immunology|September 1, 1977
Non-specific factor replaces T cells in an IgG response to soluble antigensJ R North, J T Kemshead, B A Askonas
Progress in Clinical and Biological Research|January 1, 1983
Vaccine control of malignancies induced by lymphotropic herpesvirusesM A Epstein, J R North, A J Morgan
Journal of Virological Methods|September 1, 1982
Quantification of an Epstein-Barr virus-associated membrane antigen componentJ R North, A J Morgan, J L Thompson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1982
Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomesJ R North, A J Morgan, J L Thompson, et al.
The Journal of General Virology|April 1, 1981
Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolatesS M Franklin, J R North, A J Morgan, et al.
Cancer Letters|April 27, 2001
Photodynamic therapy targeted to tumor-induced angiogenic vesselsK Kurohane, A Tominaga, K Sato, et al.
Pageof 2